Tarceva
"My Mom was diagnosed with Stage IV Non-Small Cell, Adenocarcinoma with EGFR Mutation, on December 26, 2013. She had a 8x5cm RUL mass and a 6x7cm L Adrenal mass.

  At the time of staging, her life expectancy was estimated to be around 2-4 months. She began Tarceva monotherapy within 2 weeks. Her next CT showed 25% tumor shrinkage. Her 6 month CT showed no new growth and 75% tumor shrinkage and necrosis of the RUL mass. The next two CT's were stable.

  Unfortunately, as the oncologist had warned us, the cancer no longer responded to Tarceva. She was started on Gilotrif and, over the next 4 months, it had further mets to her ribs and liver. She died April 30, 2015. 

  Tarceva gave me 14 precious months with my Mother. Tarceva was a miracle."